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Background: To identify the factors that account for differences in clinical outcomes of malaria as well as its
relationship with ethnicity, transmission intensity and parasite density.
Methods: A prospective study was conducted in nine health facilities in the Centre, Littoral and South West regions
of Cameroon, and in three ethnic groups; the Bantu, Semi-Bantu and Foulbe. Children aged one month to 13 years,
with diagnosis suggestive of malaria, were recruited and characterized using the WHO definition for severe and
uncomplicated malaria. Malaria parasitaemia was determined by light microscopy, haematological analysis using an
automated haematology analyser and glucose level by colorimetric technique.
Results: Of the febrile children screened, 971 of the febrile children screened fulfilled the inclusion criteria for
specific malaria clinical phenotypes. Forty-nine (9.2%) children had cerebral malaria, a feature that was similar across
age groups, ethnicity and gender but lower (P< 0.004) in proportion in the Centre (3.1%, 5/163) compared to the
Littoral (11.3%, 32/284) and South West (13.6%, 12/88) regions. Severe anaemia was the most frequent severe
disease manifestation, 28.0% (248/885), which was similar in proportion across the three ethnic groups but was
more prevalent in females, less than 60 months old, and the Centre region. About 20% (53/267) of the participants
presented with respiratory distress, a clinical phenotype independent of age, gender and ethnicity, but highest
(P< 0.001) in the Centre (55%, 11/20) compared to the Littoral (27.3%, 3/11) and South West (16.5%, 39/236)
regions. Uncomplicated malaria constituted 27.7% (255/920) of hospital admissions and was similar in proportion
with gender and across the three ethnic groups but more prevalent in older children (≥ 60 months) as well as in
the South West region. The density of malaria parasitaemia was generally similar across clinical groups, gender and
ethnicity. However, younger children and residents of the Centre region carried significantly higher parasite loads,
with the burden heavier in the Semi-Bantu compared to their Bantu (P= 0.009) and Foulbe (P= 0.026) counterparts
in the Centre region. The overall study case fatality was 4.8 (47/755), with cerebral malaria being the only significant
risk factor associated with death. Severe anaemia, though a common and major clinical presentation, was not
significantly associated with risk of death.
Conclusion: About half of the acutely febrile children presented with severe malaria, the majority being cases of
severe malaria anaemia, followed by respiratory distress and cerebral malaria. The latter two were less prevalent in
the Centre region compared to the other regions. Cerebral malaria and hyperpyrexia were the only significant risk
factors associated with death.
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Malaria remains one of the most widespread infectious
diseases of humankind, threatening approximately half
the world’s population and causing debilitating illness in
more than 216 million people. Morbidity and mortality
is particularly high in sub-Saharan Africa, with children
below five years at the greatest risk [1]. Plasmodium
falciparum, the deadliest of the malaria parasite species,
kills a child every 30 seconds in Africa [2] and also
wreaks significant economic havoc in highly endemic
areas, substantially decreasing Gross Domestic Product
(GDP) of affected countries relative to malaria-free
regions [3].
In endemic areas, malaria accounts for 25–35% of all
outpatients’ visits, 20–45% of hospital admissions and
15–35% of hospital deaths [4]. The clinical spectrum of
paediatric P. falciparum infections range from asymp-
tomatic parasite carriage to a febrile disease that may
develop into severe, life-threatening illness [5]. Mortality
from malaria is associated largely with the parasite’s
ability to induce severe complications, presenting as
severe anaemia, cerebral malaria and metabolic acidosis,
manifested clinically as respiratory distress. Other severe
malaria manifestations at enrolment include multiple or
prolonged convulsions, hyperlactataemia, hyperparasi-
taemia, hypoglycaemia, hyperpyrexia and intravascular
haemolysis [6,7].
The factors that determine malaria severity are not
completely understood. Despite the scaling up of the
provision of insecticide-treated nets and the increasing
use of the most rapidly parasiticidal artemisinin deriva-
tives [8,9], the risk of and mortality from malaria still
remain significantly high [1,2]. Studies on factors asso-
ciated with increased risk of developing severe malaria
and death, may provide additional understanding of the
course of severe malaria, and, eventually, lead to
improved case management, and the development of
drugs and vaccines for malaria.
Studies on paediatric malaria in Cameroon are limited
[10] and although several studies, at various settings in
Africa, have attempted to delineate the epidemiology of
clinical malaria, the data have shown significant vari-
ability across various transmission zones [6,7,11-14].
Nevertheless, severe malaria features may change
according to a number of factors including the genetic
characteristics of the population, malaria epidemiology,
health-seeking behaviour, non-malaria co-morbidity, clin-
ical assessment and local case management [14]. There
is, therefore, a need for more site-specific data in order
to appreciate the complete clinical and epidemiological
picture needed for efficient testing of candidate malaria
vaccines and other control tools in different endemic
sites. Furthermore, how the peripheral parasite density
varies with transmission or influences the different typesof manifestations of specific clinical features is poorly
described [13].
A hospital-based study was, therefore, undertaken to
determine the factors that account for different clinical
outcomes of malaria as well as its relationship with eth-
nicity, transmission intensity and parasite density in
young children from three regions with distinct eco-
logical conditions across Cameroon. The prevalence of
the clinical phenotypes in hospitals was used as a proxy
measure, although malaria disease patterns related to
transmission are best studied using incidence data [15].Methods
Study area
A prospective study was conducted in four towns dis-
tributed in three regions of Cameroon, namely: Yaounde
in the Centre; Douala in the Littoral; and Buea and
Limbe in the South West. The study sites included
hospitals (Bota District Hospital - Limbe, Laquintinie
Hospital - Douala, Mother and Child Hospital -
Yaounde, Regional Hospital - Limbe and Regional
Hospital Annex - Buea) and health centres (Bokova
Health Centre, Mount Mary Health Centre - Buea and
PMI Down Beach - Limbe). Except for Mount Mary,
the chosen health facilities were the main government
institutions in the selected towns, also receiving patients
from surrounding areas. Although malaria is endemic
throughout Cameroon, the country has very different
geographical and epidemiologic strata that may alter the
course of the infection [16].
The central region (Yaoundé) is located within the
rainforest belt of central Africa [17] and has the Guinea-
type equatorial climate [16]. This is characterised by
fairly constant temperatures ranging from 17°C to 30°C
(mean = 23.1°C) [18], abundant rainfall (1,500–2,000
mm), with the average relative humidity index ranging
from 85% to 90%, and four distinct seasons: two rainy
seasons (March–May/June, September–November) and
two dry seasons (December–February, June/July–August).
Maximal transmission of malaria occurs during and
immediately following the two rainy seasons [16-18].
Only Anopheles gambiae and Anopheles funestus contrib-
ute to malaria transmission in urban Yaoundé and their
distribution is seasonal. The entomological inoculation
rate has been estimated at 34 infectious bites per person
per year [19]. The Mother and Child Hospital is a refer-
ral hospital for children and mothers, located in the heart
of the city of Yaoundé, it also attracts patients from
neighbouring villages, such as Simbok and Etoa that are
stable, rural, farming communities with fields irrigated by
water from the Mefou and Biyeme Rivers. Inhabitants of
this region are of the Ewondo tribe and part of the Bantu
ethnic group.
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Cameroonian-type equatorial climate characterized by
fairly constant temperatures and two seasons: a short
dry season (November–March) and a long rainy season
(March-November) with abundant precipitation (2,000–
10,000 mm) [16]. In the Mt Cameroon region of the
south-west, the mean annual rainfall is 2,625 mm, rela-
tive humidity is constantly high (75%–80%), and the
temperature varies from 18°C in August to 35°C in
March [20]. In general, malaria transmission is intense
and perennial in the Littoral, and South Western
regions, with peak periods corresponding to the rainy
seasons [16].
In the Mount Cameroon region of the South West,
human malaria is meso-endemic during the dry season
but becomes hyper-endemic in the rainy season, with
incidence peaking in July–October. The prevalence of
malaria parasitaemia in the low-altitude areas ranges
from 30% in the dry season to 84% in the rainy season
[21,22]. Anopheles gambiae is the dominant (most
aggressive and most active [20,23,24] of the three malaria
vectors (An. gambiae, An. funestus and Anopheles nili),
accounting for up to 72.7% of transmission [23]. Infection
rates by An. gambiae are as high as 287 infective bites/
person/year [23] and overall EIR estimated recently at
3.93 infective bites/person/night [24]. Plasmodium falcip-
arum accounts for up to 96% of malaria infections in this
area [23].
Study design and population
The study conducted between May 2003 to December
2005 and April 2007 to August 2008 involved children
(aged one month to 13 years) with acute/mild illness,
reporting for consultation at the emergency/outpatientFigure 1 Schematic process of the screening and enrolment of febrile
South West regions of Cameroon.units of nine health facilities in the Centre, Littoral and
South West regions. The criteria for diagnosis and enrol-
ment included the standard WHO definitions [25] i.e.
the presence of asexual parasitaemia and at least one of
the following: cerebral malaria (impaired consciousness
or unarousable coma [(Blantyre coma score ≤ 2, cor-
rected for hypoglycaemia (blood glucose < 2.2 mmol/l)]
and no record of recent severe head trauma, neurological
disease or any other cause of coma); severe malaria
anaemia (haemoglobin < 5g/dL or haematocrit < 15%),
no cases of severe bleeding); convulsions before/during
admission, respiratory distress (presence of alar flaring,
intercostals or subcostal chest recession, use of accessory
muscles of respiration, or abnormally deep respiration);
hypoglycaemia (blood glucose <2.2mmol/L); hyperpyr-
exia (axillary temperature ≥400C); hyperparasitaemia
(>250,000 parasite/μL) as well as uncomplicated malaria
(fully conscious with haemoglobin≥ 8g/dL and no signs
of severity and/or evidence of vital organ dysfunction).
Individuals who fulfilled the specific inclusion criteria
and volunteered to participate after adequate sensitization
on the project objectives, methods and possible benefits/
risks were enrolled into the study (Figure 1). Caregivers
were interviewed about the presenting symptoms and
study physicians documented findings of clinical examin-
ation including weight and vital signs. Participants were
screened and assigned to their clinical disease categories
before any treatment was administered. In addition, the
course of illness, including vital signs, haematological
parameters and peripheral blood parasitaemia, were
documented for each study child from the time of enrol-
ment to the time of exit from the hospital. Patients were
seen twice daily while on admission and vital signs mea-
sured daily. However, peripheral blood parasitaemia andchildren in nine health institutions in the Centre, Littoral and
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and on discharge from the hospital, except otherwise
requested by study clinicians.
Exclusion criteria
Patients with a history of anti-malarial treatment within
two weeks prior to admission or were sickling positive
were excluded. Patients were also excluded from the
study based on evidence of other infectious disease, such
as typhoid, gastroenteritis, meningitis, malnutrition or
upper respiratory tract infections or any other identified
cause of anaemia than malaria.
Clinical evaluation and management
Medical doctors and/or nurses were involved in case
management at the different health facilities. The parti-
cipants’ axillary temperature was taken using a digital
thermometer except for infants (<2 years) for whom
rectal measurements were preferred. Information relat-
ing to age, gender, area of residence, mid-upper-arm
circumference, clinical observations (spleen size, etc)
and management/outcome were documented using a
standard Case Report Form (CRF).
Children were treated using a uniform protocol based
on standard recommendations [9,26] consisting of par-
enteral quinine at 20 mg/kg loading dose followed by
10 mg/kg maintenance dose every 12 hours typically
for three days or until the patient was able to swallow,
at which point he/she was switched to an oral dose of
10 mg/kg eight-hourly to complete a seven-day course
of treatment. Uncomplicated malaria cases were mainly
first treated with artemisinin-combination therapy
(mainly artesumate - amodiaquine) according to na-
tional guidelines and quinine sulphate was used as the
rescue drug. In addition to the specific treatment for
P. falciparum infection, children received supportive
therapy in terms of haemotransfusion for severe an-
aemia, intravenous glucose for hypoglycaemia and intra-
venous fluid for severe dehydration. Paracetamol
suppositories were administered for pyrexia, diazepam
for seizures, and nasal oxygen for respiratory distress
according to national guidelines.
Laboratory procedures
At enrolment, peripheral malaria blood smears, full
blood count and blood glucose were done for all partici-
pants. Thick and thin blood films were made, thin film
fixed with methanol and both thin and thick film stained
with 5% Giemsa (Sigma, St. Louis, USA). The malaria
parasitaemia and density were determined in the thick
blood smear under oil immersion with the 100x object-
ive, 10x eyepiece of a binocular Olympus microscope
(Olympus Optical Co., Ltd, Japan). A smear was only
considered negative if no malaria parasites were seen in50 high power fields (HPF). With each positive smear,
the level of parasitaemia was estimated by counting the
parasites against at least 200 leucocytes and using the
corresponding leucocyte count to calculate the number
of parasites/μl blood [27]. The malaria parasite species
were detected in the thin blood film. Whole blood speci-
mens were analysed for full blood count using auto-
mated Teco diagnostcs haematology analyser; blood
glucose levels were determined using colorimetric tech-
niques (Chronolab AG, Switzerland).
Administrative approvals and consent
Ethical clearance was obtained from the Institutional Re-
view Board of the University of Buea and South West Re-
gional Delegation of Public Health. A health facility was
only included in the study with the approval of its Dir-
ector and participants were only enrolled if their care-
givers gave written informed assent. The consenting
process involved the explanation of the content of the in-
formation sheets to caregivers by a responsible research
team member in the language he/she best understood
and opportunities were given for questions/clarification.
Emphasises was laid on the voluntary nature of participa-
tion and the fact that refusal had no influence on the
quality of medical care from the health facility.
Data and statistical analysis
All study data were captured on a structured case report
form bearing subject demographic and identification
numbers. All forms were reviewed before being double
entered onto a computer. Data missing at random was
dealt with by Partial case-wise deletion. Statistical ana-
lyses were performed using SPSS Statistics 17.0 (SPSS
Inc., Chicago, USA). Levels of parasitaemia were
log-transformed before analysis. The significance of dif-
ferences in prevalence were explored using Pearson’s
Chi-square or Fisher’s Exact test whereas the differences
in group means were assessed using Student’s t tests,
analyses of variance (ANOVA) with Post Hoc Tukey test
or Kruskal-Wallis test. Multivariate analysis was under-
taken using linear or logistic regression and included the
covariates: age and clinical malaria phenotype. A differ-




A total of 971 children satisfied the criteria for specific
malaria clinical phenotypes and were enrolled into the
study. These participants were admitted in the Centre
(164, 16.9%), Littoral (292, 30.1%) and South West (515,
53%) regions, from the Bantu (385, 39.6%), Semi-Bantu
(416, 42.8%), Foulbe (31, 3.2%) and other (139, 14.3%)
ethnic groups. The ethnicity was defined as the self-
Figure 2 Age-specific distribution of severe and uncomplicated malaria in three regions of Cameroon.
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mother’s could not be obtained). About 53.3% (516/969)
of the total study participants were males and majority
(57.7%, 492/852) aged below 36 months (Figure 2)
recruited during the rainy season months (95.8%, 918/
957) (Figure 3).
The median age, weight and mid upper arm circumfer-
ence were respectively 25.88 months (range: 1–156),
11.00 kg (range: 3–53) and 15.00 cm (range: 5–27). At
baseline, the mean temperature, haemoglobin and
geometric mean parasite density were 38.6°C (range:
35.7-43.0), 6.2 g/dl (range 1.3-14.7) and 8,873 parasites/μL
respectively. The proportion with fever (axillary
temperature≥37.5°C) and anaemia (haemoglobin< 11 g/dl)
were 87.9% (678/771) and 94.7% (889/939) respectively.
Other enrolment symptoms were capillary refill less than
two seconds (61%), inability to sit unaided or breastfeed
(33.8%), dehydration (8.4%), fitting (7.7%), jaundice
(5.3%), bipedal oedema (3.4%) and neck stiffness or bul-
ging fontanelle (2.6%). Reported fever, convulsions, mal-
arial chemotherapy and anti-convulsants use prior toFigure 3 Seasonal prevalence of severe and uncomplicated malaria inadmissions were 98.1% (773/788), 32.3% (246/761),
74.7% (343/459) and 21.0% (97/462) respectively.
Major clinical and prognostic features
Cerebral malaria
Although 71 (13.2%) of the children were comatose (Blan-
tyre coma score ≤2), only 6.3% (49/784) had cerebral mal-
aria (CM) (Blantyre coma score≤ 2 and plasma glucose
>2.2 mmol/l). The mean age (± SD) of CM patients was
37.85 ± 30.15 months. The frequency of CM in children
less than 60 months old (9.3%) was similar to those 60
months and above (8.8%) as well as in females (10.0%, 26/
259) compared to males (8.3%, 23/276). The proportion of
children with cerebral malaria was lower (P< 0.004) in the
Centre (3.1%, 5/163) compared to the Littoral (11.3%, 32/
284) and South West (13.6%, 12/88) regions but similar in
the Bantu (9.7%, 21/217), Semi-Bantu (8.3%, 23/277) and
Foulbe (8.0%, 2/25) ethnic groups.
Fewer children with cerebral malaria had severe an-
aemia (22.4%, 11/49) or respiratory distress (28.6%, 4/14)
compared to those without cerebral malaria [(28.8%,three regions of Cameroon.
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However, cerebral malaria patients tended to be more
hyperparasitaemic (12.5%, 6/48) and hyperpyrexic (19.1%,
9/47) compared to their non-cerebral malaria counter-
parts (6.0%, 28/463) and (13.4%, 64/477) respectively.
Apart from the higher (P= 0.019) mean haemoglobin
level in cerebral malaria patients (6.29 ± 2.34) g/dl com-
pared to that of children without (5.58± 1.98), mean age
(37.85± 30.15) months, plasma glucose (6.41± 3.57)
mmol/l and geometric mean parasite density (8,578 para-
sites/μL) were similar to those of non cerebral malaria
children. The total case fatality among children with
cerebral malaria (23.4%, 11/47) was higher than that of
children without cerebral malaria (5.6%, 26/467).
Severe malaria anaemia
Severe malaria anaemia (SMA) was the most frequent
severe manifestation of malaria, 28.0% (248/885) and
was similar in proportion across the three ethnic groups
but more prevalent in females, less than 60 month of
age and the Centre region (Table 1). The mean age
(± SD) of SMA patients was 30.96 ± 28.12 months. More
children with severe malaria anaemia (P = 0.007) had
respiratory distress (30.6%, 19/62) compared to those
without (14.9%, 26/174) (Figure 4) while fewer severe
malaria anaemic children (P = 0.002) were hyperparasi-
taemic (2.5%, 6/242) compared to their non severe
malaria anaemic counterparts (8.4%, 53/640). The
overlap of severe anaemia with cerebral malaria andTable 1 Variation in the major clinical disease phenotypes wi
Parameters N CM P value N SMA P
Age group (months)
< 60 562 41 (7.3) 0.420 637 187 (29.4) 0
≥ 60 148 8 (5.4) 158 30 (19.0)
Gender
Male 409 23 (5.6) 0.449 469 118 (25.2) 0
Female 375 26 (6.9) 415 130 (31.3)
Ethnicity
Bantu 313 21 (6.7) 0.996 358 98 (27.4) 0
Semi-Bantu 352 23 (6.5) 388 111 (28.6)
Foulbe 30 2 (6.7) 30 5 (16.7)
Location
Centre 163 5 (3.1) <0.001 162 61 (37.7) 0
Littoral 285 32 (11.2) 277 63 (22.7)
South West 336 12 (3.6) 446 124 (27.8)
Transmission
Seasonal 163 5 (3.1) 0.059 162 61 (37.7) 0
Perennial 621 44 (7.1) 723 187 (25.9)
Each participant has been categorised into one group only which clinicians felt was
lower because some parameter estimates were not taken.hyperpyrexia were 7.6% (11/145) and 12.4% (25/202) re-
spectively (Figure 4, Table 2). More children (P< 0.001)
with severe malaria anaemia at enrolment 86% (172/200)
received blood transfusions compared to cases without
severe malaria anaemia 58.3% (299/513).
The total case fatality among children with severe
anaemia (7.6%, 15/198) was similar to that of children
without SMA (5.5%, 28/509) (Table 2).
Respiratory distress
About 20% (53/267) of participants assessed presented
with respiratory distress (RD). The proportion of
children with this phenotype was independent of age,
gender and ethnicity but highest (P < 0.001) in the Centre
(55%, 11/20) compared to the Littoral (27.3%, 3/11) and
South West (16.5%, 39/236) regions. The geometric
mean parasite load of these participants was also similar
to that of patients without respiratory distress (Table 2).
Respiratory distress was significantly higher (P= 0.007) in
severe anaemia (30.6%, 19/62) patients compared to
those without SMA (14.9%, 26/174). However, the pro-
portion of children with respiratory distress was similar
in cerebral malaria patients (28.8%, 4/14) and hyperpara-
sitaemics (21.1%, 4/19) compared to those without CM
(33.7%, 28/83) and hyperparasitaemia (18.7%, 41/219
respectively). The case fatality of respiratory distress
was 13.5% (7/52) and was significantly increased to
66.7% (2/3) when the respiratory distress overlapped
with cerebral malaria plus severe anaemia (Figure 4).th age, gender, ethnicity and location of residence
value N UM P value N RD P value
.009 662 130 (19.6) <0.001 284 44 (15.5) 0.143
167 71 (42.5) 95 9 (9.5)
.042 487 133 (27.3) 0.473 192 23 (15.6) 0.082
432 109 (25.2) 230 30 (10.0)
.368 368 103 (28.0) 0.031 177 26 (14.7) 0.827
409 84 (20.5) 169 21 (12.4)
31 5 (16.1) 7 1 (14.3)
.004 163 20 (12.3) <0.001 39 11 (28.2) 0.008
288 19 (6.6) 29 3 (10.3)
469 203 (43.3) 354 39 (11.0)
.003 163 20 (12.3) <0.001 39 11 (28.2) 0.002
757 222 (29.3) 383 42 (11)
the primary phenotype; Samples numbers in some of the clinical groups are
Figure 4 Venn diagram of proportions, overlap and mortality of major clinical subgroups of malaria.
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Uncomplicated malaria (UM) was also a very frequent
manifestation constituting 26.3% (242/920) of hospital
admissions. This clinical phenotype was similar in pro-
portion with gender and across the three ethnic groups
but more prevalent in older children as well as in the
South West region (Table 2). There were fewer uncom-
plicated malaria children with respiratory distress (13%,
13/100) (Figure 4) and hyperpyrexia while the propor-
tion of hyperparasitaemia and hypoglycaemia was similar
to those of patients without the phenotype (Table 2).
The total case fatality among children with uncompli-
cated malaria (3.0%, 5/167) was significantly increased
to 15.4% (2/13) when it overlapped with respiratory dis-
tress (Figure 4).Parasitaemia
The geometric mean density of parasitaemia was gen-
erally similar in cerebral malaria (8,578 parasites/μL),
severe malaria anaemia (7,754 parasites/μL) andTable 2 Characteristics of the major clinical phenotypes
Parameter N CM N SM
Hyperpyrexia, n (%) 47 9 (19.1) 191 24
Hyperparasitaemia, n (%) 48 6 (12.5) 231 5 (2
Hypoglycaemia, n (%) 49 - 187 24
Fatality, n (%) 47 11 (23.4) 187 11
Mean age± SD (months) 49 37.85 ± 30.15 205 29.9
Mean haemoglobin ± SD (g/dl) 49 6.29 ± 2.34 225 3.65
*GMPD, parasites/μL 48 8,578 231 7,75
Mean spleen size ± SD (cm) 41 0.95 ± 1.66 124 1.51
Mean plasma glucose ± SD (mmol/l) 49 6.41 ± 3.57 187 5.91
♣Age significantly higher than the corresponding values for SMA (P < 0.001) and CM
}Spleen size significantly higher than the corresponding values for CM (P= 0.005), S
The haemoglobin values are significantly different between all four clinical groups;
was the primary phenotype. Samples numbers in some of the clinical groups are louncomplicated malaria (6,791parasites/μL) patients as
well as with gender and ethnicity. Younger children and
residents of the Centre region, however, carried signifi-
cantly higher parasite loads (Table 3). Furthermore, in
the Centre region, there was a significant variation in
parasitaemia with ethnicity (P=0.003), with higher dens-
ities in the Semi-Bantu compared to their Bantu
(P=0.009) and Foulbe (P= 0.026) counterparts (Figure 5).
Nevertheless, age was similar across ethnicity in this re-
gion. Although the difference in parasitaemia with gender
was insignificant in CM and SMA, females with uncom-
plicated malaria had higher (P=0.007) parasite loads
compared to their male counterparts.Factors associated with malaria death
The overall study case fatality was 4.8 (47/755). This was
similar in males and females (6.6% vs 5.8%), Bantu,
Semi-Bantu and Foulbe ethnic groups (5.7% vs 6.0% vs
6.9%) as well as the Centre, Littoral and South West
regions (8.7% vs 6.7% vs 4.6%). Their baselineA N UM N RD P-value
(12.6) 154 29 (18.8) 32 9 (28.1) 0.110
.2) 228 14 (6.1) 26 3 (11.5) 0.008
(12.8) 177 18 (10.2) 26 4 (15.4) 0.617
(5.4) 154 3 (1.9) 33 5 (15.2) <0.001
6± 27.33 201 51.41 ± 38.81♣ 33 40.28 ± 34.33 <0.001
± 0.83 222 9.60 ± 1.31 31 7.71 ± 2.27 <0.001
4 228 6,791 26 17,512 0.346
± 2.37 104 1.08 ± 1.94 15 3.13 ± 3.04} 0.004
± 4.41 177 6.23 ± 6.33 26 4.63 ± 4.25 0.474
(P= 0.050).
MA (P= 0.033) and UM (P= 0.004).
each participant has been categorised into one group only which clinicians felt
wer because some parameter estimates were not taken.
Table 3 Variation in geometric mean malaria parasitaemia density with age, gender, ethnicity and location across the
major clinical subgroups
Parameters N All subjects N CM n SMA n UM P value
Age group
< 60 642 10,451 40 8,940 177 10,089 120 6,791 0.415
≥ 60 159 5,998 8 6,978 27 2,037 68 8,954♣ 0.046
P value 0.013 0.831 0.001 0.504
Gender
Male 472 7,773 22 7,968 110 7,636 126 4,405 0.223
Female 421 10,293 26 9,130 121 7,862 102 11,592 0.582
P value 0.087 0.876 0.835 0.007
Ethnicity
Bantu 360 9,134 21 6,246 90 7,962 96 7,638 0.927
Semi-Bantu 391 11,171 23 10,993 103 9,670 79 10,194 0.973
Foulbe 30 9,387 2 4,205 5 1,336 5 13,402 0.522
P value 0.539 0.789 0.156 0.738
Location
Centre 162 17,640{ 5 9,908 60 10,336 20 43,031} 0.014
Littoral 281 7,292 32 6,296 58 5,243 18 7,385 0.873
South West 452 7,836 11 19,756 113 8,136 190 5,540 0.161
P value 0.001 0.547 0.258 0.005
Transmission
Seasonal 162 17,640 5 9,908 60 10,336 20 43,031} 0.014
Perennial 733 7,623 43 8,435 171 7,010 208 5,686 0.555
P value <0.001 0.910 0.296 0.001
Each participant has been categorised into one group only which clinicians felt was the primary phenotype; ♣Significantly higher than the corresponding values
for SMA (P= 0.035).
}Significantly higher than the corresponding values for SMA (P= 0.006) and patients from the South West region (P= 0.004).
{Significantly higher than the corresponding values for the Littoral (P = 0.001) and South West regions (P= 0.002).
Each participant has been categorised into one group only which clinicians felt was the primary phenotype; Samples numbers in some of the clinical groups are
lower because some parameter estimates were not taken.
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http://www.malariajournal.com/content/11/1/215presentations were: age less than 60 months 91.1% (41/
45), respiratory distress 46.7% (7/15), severe malaria an-
aemia 34.9% (15/43), cerebral malaria 29.7% (11/37),
hyperpyrexia 27.3% (12/44), hypoglycaemia 21.4% (9/Figure 5 Variation of geometric mean malaria parasitaemia density a
Cameroon.42) and hyperparasitaemia 11.1% (5/45). Bivariate ana-
lysis (Table 4) showed that cerebral malaria, hyperpyr-
exia, hypoglycaemia and respiratory distress were the
risk factors associated with most deaths but logisticnd age with ethnicity of children from the central region of
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http://www.malariajournal.com/content/11/1/215regression analysis showed that cerebral malaria and
hyperpyrexia were associated with malaria death.
Discussion
Studies on severe malaria in Cameroonian children are
limited, in spite of the several advantages that severe
malaria offers over other potential endpoints (such as
death) for future malaria vaccine efficacy trials, the scal-
ing up of the provision of insecticide-treated nets and
the adoption of new effective therapeutics. Furthermore,
it is not clear how the peripheral parasite density varies
with transmission or influences the different types of se-
vere malaria clinical features. This study sets out to de-
termine the factors that account for different clinical
outcomes of malaria parasite infection as well as its rela-
tionship with ethnicity, transmission intensity and para-
site density in young children from three regions with
distinct ecological conditions across Cameroon. The
results showed that significant hospital admissions and
numbers of severe malaria cases exist in the Centre,
Littoral and South West regions of Cameroon and that
severe malaria in this setting may represent an adequate
vaccine trial endpoint [7,28].
The current study showed that over a period of 48
months, 971 (49.4%) hospital-based malaria cases were
recruited, the majority (57.7%, 492/852) aged below 36
months, with a significant decreasing trend towards in-
creasing age (Figure 2). The proportion of severe cases
(57.2%) was highest in children less than 24 months as
reported elsewhere [7,14] supporting the observed asso-
ciation between age and disease severity. As in some set-
tings, the predominant manifestation was severe malarial
anaemia. Other clinical and laboratory manifestations
were also consistent with what had earlier been reported
in other endemic settings [6,7,11,13,14,29].
The mean age of children with severe malaria anaemia
and cerebral malaria was 30.96 and 37.85 monthsTable 4 Prognostic indicators at the time of enrolment
Outcome Prevalence [n (%)] Fatalities [n (%)]
Cerebral malaria 49 (5.0) 11 (22.4)
Severe malaria anaemia 248 (25.5) 15 (7.6)
Uncomplicated malaria 242 (24.9) 3 (1.9)
Hyperparasitaemia 58 (6.0) 5 (9.8)
Hyperpyrexia 116 (11.9) 12 (10.8)
Hypoglycaemia 89 (9.2) 9 (12.9)
Respiratory distress 53 (5.5) 7 (13.5)
Hypoglycaemia 89 (9.2) 9 (12.9)
Respiratory distress 53 (5.5) 7 (13.5)
N=971.respectively (Table 1), consistent with results from previ-
ous studies that severe anaemia is more common in
infants and young children <36 months while cerebral
malaria is commoner in older children [14,25]. Never-
theless, this should be interpreted with caution, as the
assessment of neurological status in children younger
than eight months, and therefore the percentage of those
with low Blantyre coma scores, is unreliable in this age
group [30].
There was a significant variation in the age of paediat-
ric malaria admissions and the proportion of the differ-
ent clinical groups in the three regions (Table 1). The
latter may reflect differences in parasite and/or vector
virulence or transmission intensities, but may also echo
the difficulties in measuring cerebral malaria (and per-
haps other phenotypes) in very young children [29]. The
observed age difference is consistent with the view that
the speed of acquired anti-disease immunity depends on
the frequency of parasite exposure since birth. Such vari-
ation in background immunity may also explain the dif-
ferences in the age of presentation of severe malaria as
reported previously [6,14] or other undefined variables.
More importantly the difference in peak age of hospita-
lized malaria presentation has implications for the de-
sign of prevention strategies planned for the control of
malaria in Africa. The benefit of targeted intervention in
the use of bed nets to the highest risk groups and inter-
mittent preventive treatment in infants (IPTi) must
adapt to include increasingly older age risk groups in
order to have greater impact. Universal coverage is now
the aim whenever resources allow.
It is not surprising that children aged below 60
months carried the greater malaria parasite burden com-
pared to their older counterparts (Table 2) and that
parasitaemia correlated inversely with age (data not
shown). Residents of malaria-endemic areas have long
periods of malaria parasitaemia punctuated by episodicUnivariate analysis Multivariate analysis
χ2 P value OR 95%
CI
20.337 < 0.001 20.17 1.82-223.47
1.101 0.294 2.65 0.38-18.56
5.541 0.019 1.18 0.09-15.83
1.119 0.290 0.14 0.01-1.70
5.479 0.019 11.33 1.60-80.02
4.601 0.032 0.96 0.87-1.06
7.134 0.013 3.22 0.36-29.02
4.601 0.032 0.96 0.87-1.06
7.134 0.013 3.22 0.36-29.02
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pattern has been explained by the acquisition of anti-
disease/anti-toxic immunity in early childhood and later
anti-parasitic immunity following repeated exposure to
malaria [31]. However, parasite loads were similar across
clinical groups, except in the Centre region (Table 2),
suggesting that the density of malaria infection is not a
significant factor in determining disease severity. Never-
theless, the observed differences in the Centre corrobor-
ate previous reports [13,14] suggesting that heavy
P. falciparum malaria parasitaemia may be important in
the development of seizures, severe anaemia and
impaired consciousness or deep coma. Additionally,
sequestered parasites have been implicated in the path-
ology of severe malaria manifestations [32] so that per-
ipheral parasitaemia, on average, is not expected to show
significant associations with clinical manifestations.
Taken together, correlation between severity of disease
and peripheral parasitaemia is not clear-cut and the lat-
ter may only play a small role in the overall complexity
of severe malaria syndromes.
Surprisingly, malaria parasitaemia varied with ethni-
city in the Centre region (Figure 5). This is unlikely
due to age since age was similar (P= 0.403) across these
ethnic groups in the region. Also, since these indivi-
duals live in the same region, location cannot account
for the difference observed. The finding seems to sug-
gest that Semi-Bantu are more susceptible compared to
the Bantu and Foulbe. Several studies have demon-
strated differences in susceptibility to malaria, with the
Fulani of West Africa having a lower incidence of mal-
aria than other sympatric groups [33] and the Fulani in
Burkina Faso being less parasitized than the sympatric
Mossi and Rimaibé groups [34]. This is also true for
the Malian Fulani and their sympatric neighbours, the
Dogon [35]. Various markers confirm that the Fulani
are genetically distinct from other African tribes [36].
Such genetic differences may be less apparent in the
Littoral and South West regions due to extensive ethnic
mixing. However, previous results have also shown that
this relative resistance to malaria in the Fulani, as com-
pared to other sympatric tribes, appears to be pathogen
related and not due to a general hyper-reactive immune
system [37].
The overall case fatality in this study was 4.8%; this
was similar by gender (3.3% vs. 3.7%), age groups (3.3%
vs. 3.9%), ethnicity and location. This observation is
higher than previous reports in Africa [7,13,14] but may
even be an underestimation, as some children might
have died at home during the period since a majority of
cases of untreated severe and complicated malaria are
fatal. The independent prognostic indicator was cerebral
malaria confirming the fact that in severe malaria,
neurological involvement is the factor that is mostassociated with poor outcome [7,11,13]. Severe anaemia,
though the most frequent presenting feature, was a poor
predictor of death [38], perhaps because most severe
malaria anaemia children received timely blood transfu-
sion. Despite this, severe anaemia will be an important
vaccine trial endpoint because of its frequency, especially
in infants and because of the ease with which it can be
measured with certainty in field situations.
Even though mortality impact is the most important
public health measure of any vaccine efficacy, it repre-
sents a smaller proportion of all disease burdens and
will, thus, require large sample size in future trials [7].
Again the comparative ease of using the established case
definitions of severe malaria [25] and the fact that most
children diagnosed as having severe malaria have worse
prognoses than those with mild disease makes severe
malaria a better trial endpoint. Well-defined severe mal-
aria, therefore, bridges the gap of being common enough
for a reduction to be measurable and as important as
possible to predict malaria-associated mortality in en-
demic sites [28].
A significant seasonal variation of the prevalence of se-
vere malaria was recorded over the study period
(Figure 3). The highest prevalence occurred in the
months of April to October (during the rainy season).
The observed pattern points to the fact that increase in
vector breeding following the rainy season is responsible
for the upsurge in the malarial cases and supports an
earlier transmission study [20]. In malaria endemic
areas, majority of malaria death and morbidity occur
during the peak transmission seasons. As such, the inter-
mittent preventive treatment approaches to malaria con-
trol during this intense period could impact on reducing
disease burden. Such preventive measures could reduce
the risk of severe malaria and subsequently minimize its
effect as a vaccine trial endpoint.Conclusion
Results from this study suggest that significant hospital
admissions and numbers of severe malaria cases exist in
the Centre, Littoral and South West regions of Camer-
oon. In addition, severe malaria in these areas occurs
frequently in the first 24 months of life, the predominant
feature being severe anaemia while cerebral malaria and
hyperpyrexia were the independent prognostic indicator
of death. Although the variation of parasitaemia with
ethnicity in the Centre region seems to suggest that
Semi-Bantu are more susceptible compared to the Bantu
and Foulbe, the differences observed may be pathogen
related and not due to a general hyper-reactive immune
system as previously reported. Such genetic differences
may be less apparent in the Littoral and South West due
to extensive ethnic mixing.
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